Scientific and clinical research is at the core of InGeneron. We believe in the collective benefit of collaborating with and receiving input from other research-driven organizations. Collaboration advances knowledge in treating medical conditions that might benefit from regenerative cell therapy. We value the prospect of engaging with researchers and institutions that have an interest in our clinical development plan and programs.
Our initial focus is on musculoskeletal indications, including pain management. Autologous cell therapies also hold promise for numerous other indications, and we are interested in discussing program ideas that are outside our current focus. This might include both preclinical research and investigator-initiated studies that a researcher or institution sponsors and for which InGeneron provides support.